Birgit Reitmaier is Head of Access to Innovation
APAC at the Biopharma division of Merck. In this role she scouts for and
transacts on collaboration opportunities in the APAC region. She has worked in
business development at Merck since 2009. Prior to that Birgit worked for a
skin-research focused biotechnology company near Munich, as Project Director.
She obtained her MBA from Henley Management College and her doctorate in
chemistry from the University of Mainz. Merck is a leading science and
technology company in healthcare, life science and performance materials. More
than 50,000 employees work to further develop technologies that improve and
enhance life – from biopharmaceutical therapies to treat cancer or multiple
sclerosis, cutting-edge systems for scientific research and production, to
liquid crystals for smartphones and televisions. In 2018, Merck generated sales
of €14.8 billion in 66 countries. Founded in 1668, Merck is the world's oldest
pharmaceutical and chemical company.